
|Articles|December 16, 2008
Sol-Gel unveils new research facilities
Ness Ziona, Israel - Sol-Gel Technologies unveiled a new plant with state-of-the-art facilities for the development of topical dermatology drugs, according to a press release.
Advertisement
Ness Ziona, Israel
- Sol-Gel Technologies unveiled a new plant with state-of-the-art facilities for the development of topical dermatology drugs, according to a press release.
The new plant houses research, development and analytical laboratories, pilot production facilities and management offices, according to the company.
Sol-Gel is working to develop a new anti-acne kit.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5

















